Intervision Global Ltd provide bespoke inline inspection systems for the automotive, food & beverage, life science, medical device and pharmaceutical industries. Set up in 2004 as V-Viz Ltd, Intervision Global have built a reputation as an experienced and reliable expert in inspection system design, specification, installation and support, and have a global blue-chip customer base. As an approved supplier to one of the largest orthopaedic implant manufacturers in the world, Intervision Global have identified a market need for a flexible inspection system for orthopaedic implants. The proposed Automated Implant Verification & Identification System (AIVIS) will be able to verify the product and size type as well as uniquely identify the component with a laser mark for identification and serialisation. Wrong labelling and manufacturing issues contributed to the recall of 1287 knee and hip replacement implants between 2002 and 2013 in the US, which is why medical device regulations demand that processes are properly validated. Validation of processes adds a significant amount of time and effort to the development cycle for new orthopaedic implants. The advantage of the proposed AIVIS system is that it will be designed to remove much of the burden of validation. This is because instead of having to validate a bespoke inspection and laser marking system for each new product, the system will be supplied in a validation-ready condition and can be easily adapted for use with subsequent new designs without having to go through the full validation process. This will deliver significant savings for orthopaedic implant manufacturers and allow them to bring new products to market more quickly. Better-performing, longer-lasting implants are needed because the global orthopaedics market is growing at a Compound Annual Growth Rate (CAGR) of 5% from £19.2bn in 2012, including an increasing number of younger patients who want to remain active and are likely to live longer.